16820346|t|Atorvastatin prevented and reversed dexamethasone-induced hypertension in the rat.
16820346|a|To assess the antioxidant effects of atorvastatin (atorva) on dexamethasone (dex)-induced hypertension, 60 male Sprague-Dawley rats were treated with atorva 30 mg/kg/day or tap water for 15 days. Dex increased systolic blood pressure (SBP) from 109 +/- 1.8 to 135 +/- 0.6 mmHg and plasma superoxide (5711 +/- 284.9 saline, 7931 +/- 392.8 U/ml dex, P < 0.001). In this prevention study, SBP in the atorva + dex group was increased from 115 +/- 0.4 to 124 +/- 1.5 mmHg, but this was significantly lower than in the dex-only group (P' < 0.05). Atorva reversed dex-induced hypertension (129 +/- 0.6 mmHg, vs. 135 +/- 0.6 mmHg P' < 0.05) and decreased plasma superoxide (7931 +/- 392.8 dex, 1187 +/- 441.2 atorva + dex, P < 0.0001). Plasma nitrate/nitrite (NOx) was decreased in dex-treated rats compared to saline-treated rats (11.2 +/- 1.08 microm, 15.3 +/- 1.17 microm, respectively, P < 0.05). Atorva affected neither plasma NOx nor thymus weight. Thus, atorvastatin prevented and reversed dexamethasone-induced hypertension in the rat.
16820346	0	12	Atorvastatin	ChemicalEntity	D000069059
16820346	36	49	dexamethasone	ChemicalEntity	D003907
16820346	58	70	hypertension	DiseaseOrPhenotypicFeature	D006973
16820346	78	81	rat	OrganismTaxon	10116
16820346	97	108	antioxidant	ChemicalEntity	D000975
16820346	120	132	atorvastatin	ChemicalEntity	D000069059
16820346	134	140	atorva	ChemicalEntity	D000069059
16820346	145	158	dexamethasone	ChemicalEntity	D003907
16820346	160	163	dex	ChemicalEntity	D003907
16820346	173	185	hypertension	DiseaseOrPhenotypicFeature	D006973
16820346	210	214	rats	OrganismTaxon	10116
16820346	233	239	atorva	ChemicalEntity	D000069059
16820346	279	282	Dex	ChemicalEntity	D003907
16820346	371	381	superoxide	ChemicalEntity	D013481
16820346	426	429	dex	ChemicalEntity	D003907
16820346	480	486	atorva	ChemicalEntity	D000069059
16820346	489	492	dex	ChemicalEntity	D003907
16820346	596	599	dex	ChemicalEntity	D003907
16820346	624	630	Atorva	ChemicalEntity	D000069059
16820346	640	643	dex	ChemicalEntity	D003907
16820346	652	664	hypertension	DiseaseOrPhenotypicFeature	D006973
16820346	737	747	superoxide	ChemicalEntity	D013481
16820346	764	767	dex	ChemicalEntity	D003907
16820346	784	790	atorva	ChemicalEntity	D000069059
16820346	793	796	dex	ChemicalEntity	D003907
16820346	818	825	nitrate	ChemicalEntity	D009566
16820346	826	833	nitrite	ChemicalEntity	D009573
16820346	835	838	NOx	ChemicalEntity	D009589
16820346	857	860	dex	ChemicalEntity	D003907
16820346	869	873	rats	OrganismTaxon	10116
16820346	901	905	rats	OrganismTaxon	10116
16820346	976	982	Atorva	ChemicalEntity	D000069059
16820346	1007	1010	NOx	ChemicalEntity	D009589
16820346	1036	1048	atorvastatin	ChemicalEntity	D000069059
16820346	1072	1085	dexamethasone	ChemicalEntity	D003907
16820346	1094	1106	hypertension	DiseaseOrPhenotypicFeature	D006973
16820346	1114	1117	rat	OrganismTaxon	10116
16820346	Negative_Correlation	D009589	D003907	Novel
16820346	Negative_Correlation	D009573	D003907	Novel
16820346	Negative_Correlation	D009566	D003907	Novel
16820346	Positive_Correlation	D003907	D013481	Novel
16820346	Positive_Correlation	D003907	D006973	No
16820346	Negative_Correlation	D000069059	D006973	Novel
16820346	Negative_Correlation	D000069059	D003907	Novel